ClinicalTrialsFinder

Diffuse Large B Cell Lymphoma Refractory Clinical Trials in Taipei

1 recruitingTaipei, Taiwan

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies

Follicular Lymphoma ( FL)Diffuse Large B Cell Lymphoma RefractoryDiffuse Large B Cell Lymphoma Relapsed
GenomeFrontier Therapeutics TW Co., Ltd.18 enrolled1 locationNCT06703892